Institutional Ownership Edwards Lifesciences Corp (EW)
This table provides information about the institutional ownership of Edwards Lifesciences Corp (EW). We have compiled data on the 1,348 institutions that hold shares in the stock, with a total of 457 Million shares, which have been reported (via 13F filing form) to have a value of $33.6 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
62,594,542
shares
|
$4.6 Billion
0.08% of portfolio
|
Q3 2024
Added 16.83%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
50,975,492
shares
|
$3.74 Billion
0.11% of portfolio
|
Q2 2024
Reduced 2.75%
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
31,532,725
shares
|
$2.32 Billion
0.37% of portfolio
|
Q3 2024
Added 86.33%
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
26,265,633
shares
|
$1.93 Billion
0.07% of portfolio
|
Q3 2024
Added 0.99%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
13,521,147
shares
|
$993 Million
0.07% of portfolio
|
Q3 2024
Added 2.15%
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Nov 12, 2024 Q3 2024 |
9,078,311
shares
|
$667 Million
0.25% of portfolio
|
Q3 2024
Added 9.75%
|
|
Jpmorgan Chase & CO
New York, NY |
Dec 26, 2024 Q3 2024 |
8,466,048
shares
|
$622 Million
0.05% of portfolio
|
Q3 2024
Reduced 2.45%
|
|
Brown Advisory Inc
|
Nov 13, 2024 Q3 2024 |
7,579,656
shares
|
$556 Million
0.65% of portfolio
|
Q3 2024
Reduced 54.21%
|
|
Ninety One Uk LTD
London, X0 |
Nov 12, 2024 Q3 2024 |
7,311,728
shares
|
$537 Million
1.34% of portfolio
|
Q3 2024
Added 1658.65%
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2024 Q3 2024 |
6,983,259
shares
|
$513 Million
0.16% of portfolio
|
Q3 2024
Reduced 65.67%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
6,250,279
shares
|
$459 Million
0.17% of portfolio
|
Q3 2024
Added 68.89%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
6,005,789
shares
|
$441 Million
0.1% of portfolio
|
Q3 2024
Added 1.03%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
5,720,762
shares
|
$420 Million
0.03% of portfolio
|
Q3 2024
Reduced 12.67%
|
|
Legal & General Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
5,355,811
shares
|
$393 Million
0.08% of portfolio
|
Q3 2024
Reduced 0.63%
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
5,339,382
shares
|
$392 Million
0.06% of portfolio
|
Q3 2024
Reduced 6.59%
|
|
Sands Capital Management, LLC
Arlington, VA |
Nov 13, 2024 Q3 2024 |
5,338,095
shares
|
$392 Million
1.12% of portfolio
|
Q3 2024
Reduced 5.5%
|
|
Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust
|
Oct 21, 2024 Q3 2024 |
4,500,000
shares
|
$330 Million
3.96% of portfolio
|
Q3 2024
Added 9.76%
|
|
Nordea Investment Management Ab
Stockholm, V7 |
Jan 06, 2025 Q4 2024 |
4,057,013
shares
|
$298 Million
0.33% of portfolio
|
Q4 2024
Added 34.63%
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
3,733,777
shares
|
$274 Million
0.32% of portfolio
|
Q3 2024
Added 4900.64%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 14, 2024 Q3 2024 |
3,693,663
shares
|
$271 Million
0.99% of portfolio
|
Q3 2024
Added 239.89%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
3,659,102
shares
|
$269 Million
0.05% of portfolio
|
Q3 2024
Added 1.47%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
3,541,783
shares
|
$260 Million
0.03% of portfolio
|
Q3 2024
Reduced 51.72%
|
|
Amundi
Paris, I0 |
Nov 13, 2024 Q3 2024 |
3,482,408
shares
|
$256 Million
0.09% of portfolio
|
Q3 2024
Reduced 33.26%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
3,386,489
shares
|
$249 Million
0.06% of portfolio
|
Q3 2024
Added 10.9%
|
|
Australian Super Pty LTD
|
Oct 28, 2024 Q3 2024 |
3,273,416
shares
|
$240 Million
1.1% of portfolio
|
Q3 2024
Added 17.8%
|